Aligos and Xiamen Amoytop sign deal for HBV therapy
Aligos remains eligible for up to $420m in milestones and tiered, high single-digit royalties on Amoytop’s net sales.
Drug Manufacturers
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design
CordenPharma leases space at Flatiron Park for peptides development
Europe’s pharma trade with the US remains critical despite tariff turmoil
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m
NorthX Biologics and Demeetra collaborate on GMP manufacturing and CLD
AbbVie announces $380m investment in North Chicago API facilities
